ISRCTN13467677已完成未知
Financial incentives for hypertension control among community-based hypertensive populations: a multi-center, randomized controlled trial
Shengjing Hospital of China Medical University0 个研究点目标入组 207 人开始时间: 2019年5月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 207
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35862120/ (added 22/07/2022) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32014046/ (added 10/06/2024)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 35 - 75 years
- •2. Uncontrolled hypertensive patients (SBP/DBP = 140/90mmHg)
- •3. Have WeChat and use skillfully
- •4. Local residents, who live in local places for more than 12 months
- •5. Voluntarily joined and signed informed consents
排除标准
- •1. Pregnant women or women who are planning to become pregnant in the next year
- •2. Plans to move from the neighborhood in the next year
- •3. Malignant tumors or severe liver, kidney dysfunction
- •4. Can not be proficient in using WeChat
- •5. Secondary hypertension patients
- •6. Disagree to participate in the study or cannot give the informed consent
研究者
相似试验
已完成
不适用
ENhanced Control of Hypertension ANd Thrombolysis strokE stuDyISRCTN82387104The George Institute for Global Health (Australia)4,587
已完成
不适用
A novel approach to treatment of hypertension in diabetic patients - A multicenter, double-blind, randomised study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design.Essential Hypertension grade I and IICirculatory SystemHypertensionISRCTN55725285Solvay Pharmaceuticals (Germany)
已完成
不适用
Monetary Incentives and Intrinsic Motivation to Sustain Hypertension ControlHypertensionNCT01402453University of California, Los Angeles207
进行中（未招募）
不适用
Behavioral Economics to Improve Antihypertensive Therapy AdherenceMedication AdherenceHypertensionNCT04029883Cedars-Sinai Medical Center60
进行中（未招募）
不适用
Personalized management of high blood pressure in Anhui, ChinaCirculatory SystemHypertensionISRCTN10999269ational Natural Science Foundation of China3,420